Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show ...

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...

Autoimmune diseases disproportionately affect women, and Black women face higher rates of misdiagnosis, delayed treatment, ...

A new multiple sclerosis (MS) research project designed to help the brain repair itself by activating its own healing ...

For the first time, researchers have identified that inflammation—long associated with multiple sclerosis (MS)—appears to ...

A 6-month ketogenic diet and 2-month calorie-restricted diet were associated with significant reductions in biological age in ...

With symptoms that can be unpredictable and range from mild to severe, multiple sclerosis (MS) can be an overwhelming diagnosis. A chronic disease of the central nervous system, MS disrupts ...

A study suggests anti-inflammatory and neuroprotective properties in fish can help, even later in the disease course. Find ...

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects ...